4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-041774
President and CEO sold 2,115 shares at $5.18 ($10,948)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-07-08 | Sale : show line 1 in the form | −2,115 | $5.18 | $10,948 | 628,791 | D |
| Open-market sales · 2,115 sh · avg $5.18 · $10,948 | ||||||
Loading xslF345X03/doc4.xml…